Surgery

Medicine & Life Sciences

1. Adenocarcinoma 14%
2. Allografts 37%
3. Anus Neoplasms 11%
4. Bariatric Surgery 34%
5. Biopsy 13%
6. Blood Vessels 19%
7. Bone and Bones 11%
8. Breast 29%
9. Breast Cancer Lymphedema 11%
10. Breast Neoplasms 36%
11. Cadaver 12%
12. Child 18%
13. Colorectal Neoplasms 19%
14. Confidence Intervals 14%
15. Coronavirus 17%
16. Cyclosporine 22%
17. Databases 14%
18. Demography 11%
19. Diagnosis-Related Groups 19%
20. Drug Therapy 12%
21. Endostatins 14%
22. Free Tissue Flaps 13%
23. Gastrectomy 18%
24. Gastric Bypass 29%
25. Graft Survival 33%
26. Groin 11%
27. Growth 11%
28. Guidelines 22%
29. Healthcare Financing 13%
30. Hemorrhage 15%
31. Hernia 11%
32. Herniorrhaphy 21%
33. Hyperparathyroidism 14%
34. Immunosuppression 16%
35. Incidence 17%
36. Infections 12%
37. Inguinal Hernia 14%
38. Kidney 85%
39. Kidney Transplantation 48%
40. Laparoscopy 17%
41. Lasers 13%
42. Length of Stay 21%
43. Liver 26%
44. Liver Transplantation 15%
45. Mammaplasty 24%
46. Melanoma 12%
47. Melphalan 12%
48. Mesenteric Ischemia 17%
49. Morbidity 13%
50. Mortality 24%
51. Multiple Endocrine Neoplasia Type 1 15%
52. Neoplasm Metastasis 24%
53. Neoplasms 60%
54. Nephrectomy 17%
55. Neuroendocrine Tumors 27%
56. Oncologists 24%
57. Palliative Care 11%
58. Pancreas 19%
59. Pancreas Transplantation 15%
60. Pandemics 21%
61. Pathologic Constriction 11%
62. Pathologists 13%
63. Pediatrics 28%
64. Perfusion 28%
65. Peritoneal Diseases 15%
66. Peritoneal Neoplasms 39%
67. Physicians 13%
68. Plastic Surgery 22%
69. Population 13%
70. Quality Improvement 14%
71. Radiation 12%
72. Radiotherapy 15%
73. Recurrence 20%
74. Registries 12%
75. Reoperation 17%
76. Robotics 16%
77. Safety 14%
78. Segmental Mastectomy 21%
79. Semiconductor Lasers 15%
80. Serum 11%
81. Skin 13%
82. small inducible cytokine subfamily E, member 1 13%
83. Squamous Intraepithelial Lesions 12%
84. Stomach 21%
85. Stomach Neoplasms 16%
86. Surgeons 55%
87. Surgical Wound Infection 12%
88. Survival 35%
89. Sutures 19%
90. Tacrolimus 23%
91. Technology 11%
92. Therapeutics 31%
93. Tissue Donors 49%
94. Transplant Recipients 42%
95. Transplantation 31%
96. Transplants 100%
97. Tumor Necrosis Factor-alpha 20%
98. Ventral Hernia 15%
99. Weight Loss 16%
100. Wounds and Injuries 28%